Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosed with UC for at least 12 weeks prior to screening
Screening colonoscopy for colorectal cancer conducted within the prior two years if a history of pancolitis with disease duration ≥ 8 years or history of left-sided colitis and disease duration ≥12 years
Evidence of disease activity at time of screening
Insufficient clinical response to standard of care (SOC) therapy or intolerance to SOC
You may not be if
Diagnosis of Crohn's disease or indeterminate colitis
History of infection with hepatitis B, human immunodeficiency virus (HIV), active hepatitis C virus (HCV) infection, or other chronic infection
Active infections requiring systemic therapy with antibiotic, antiviral or antifungal or febrile illness within 7 days before Day -1
History of primary or acquired immunodeficiency
Abnormal hematologic values
Abnormal hepatic enzyme or hepatic function values
Clareo Health | Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)
